Cargando…

Profile of Intestinal Microbiota and Anxiety Level in Overweight Children and Adolescents

Justification: Obesity is considered a worldwide epidemic, with a significant increase in its prevalence in the last 30 years in both children and adolescents. Anxiety disorders can be considered both a cause and a consequence of obesity. The intestinal microbiota has been identified as a participan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandeira Farias, Maria Paula Costa, Carvalho, Bruno, Neto, Adauto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265708/ http://dx.doi.org/10.1210/jendso/bvab048.048

Ejemplares similares

ODP003 Different Phenotypes of Obesity: Focus on The Intestinal Microbiom and The Adipomyokin Profile
por: Volkova, Natalya, et al.
Publicado: (2022)

Cancer Risk of Patients With Overweight and Obesity: A Predictive Model
por: Turchin, Alexander, et al.
Publicado: (2021)

FRI010 Human Gut Microbiota And Metabolic Profiles Are Associated With Obesity In Five African-Origin Populations
por: Jorgensen, Julianne, et al.
Publicado: (2023)

SAT-103 Assessing Factors Influencing Eating in Overweight and Obese Individuals
por: DiBenedetti, Dana, et al.
Publicado: (2019)

No Differences in Metabolic Parameters Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy, Regardless of Achieved Weight Loss
por: Holanda, Narriane Chaves Pereira, et al.
Publicado: (2021)

FRI007 Kisspeptin Does Not Affect Food Intake In Women With Overweight Or Obesity
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

Neurobiology of Avoidant/Restrictive Food Intake Disorder in Youth With Overweight/Obesity Versus Healthy Weight
por: Liya, Kerem, et al.
Publicado: (2021)

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study
por: Wilding, John P H, et al.
Publicado: (2021)

SAT659 Prevalence Of Multimorbidity Across Age Groups Among Us Adults With Overweight Or Obesity
por: Ezendu, Kyrian, et al.
Publicado: (2023)

SAT657 Work Loss Among Privately Insured Employees With Overweight And Obesity In The United States
por: Shinde, Shraddha, et al.
Publicado: (2023)

SAT-096 Later Timing of Energy Intake Associates with Higher Fat Mass in Adults with Overweight and Obesity
por: Zaman, Adnin, et al.
Publicado: (2019)

ODP009 Obesity-related Conditions in Adults with Overweight and Obesity in the United States: A Cluster Analysis
por: Chiu, Kevin, et al.
Publicado: (2022)

FRI030 The Clinical Significance Of The Oxidative Status Evaluation Among Insulin Resistant Overweight And Obese Patients
por: Popławska-Kita, Anna, et al.
Publicado: (2023)

SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US
por: Ezendu, Kyrian, et al.
Publicado: (2023)

ODP004 Glucose Profiles and Insulin Sensitivity in Adults with Overweight/Obesity Participating in a Weight Loss Intervention based on Early Time-Restricted Eating plus Daily Caloric Restriction vs Daily Caloric Restriction Alone
por: Jeffers, Rebecca, et al.
Publicado: (2022)

SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019)

Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide 2.4 MG in Adults With Overweight or Obesity (STEP 1)
por: Wilding, John P H, et al.
Publicado: (2021)

FRI050 A Cross-sectional Study Of Parental Outdoor Play Preferences And Association With Child Overweight And Obesity
por: Gavryutina, Irina, et al.
Publicado: (2023)

SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
por: Srinath, Reshmi, et al.
Publicado: (2023)

Serum Levels of Lipocalin Are Lower in Adolescents With X-Linked Hypophosphatemia
por: Simpson, Christine A, et al.
Publicado: (2021)

Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2)
por: Davies, Melanie, et al.
Publicado: (2021)

ODP014 Safety and Efficacy of IBI362 (LY3305677) 9 mg and 10 mg in Chinese Adults with Overweight or Obesity
por: Ji, Linong, et al.
Publicado: (2022)

FRI029 Chronic Free Fatty Acid Elevation Is Associated With An Overcompensatory Increase In Hepatic Mitochondrial Function In Patients With Overweight Or Obesity
por: Bril, Fernando, et al.
Publicado: (2023)

OR20-3 The Relationship of Obesity Severity, Triglycerides, and Elevated ALT Levels in Adolescents
por: Wu, Stephanie, et al.
Publicado: (2019)

Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)
por: Rubino, Domenica M, et al.
Publicado: (2021)

MON-112 Gelesis100 Reduces Insulin Resistance in Patients Who Are Overweight or Have Obesity with High Insulin Resistance: Results of the GLOW Study
por: Greenway, Frank, et al.
Publicado: (2019)

Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)
por: Kushner, Robert F, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus Remission in Obese Patients Under Bariatric Surgery: The Role of Preoperative Triglycerides Levels
por: Gonçalves, Vanessa Guerreiro, et al.
Publicado: (2021)

SAT679 Telehealth And Metabolic Health: Unraveling The Effects Of A 12-week Low-starch Diet On Homa2B IR In Overweight Women
por: Erta, Gita, et al.
Publicado: (2023)

OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial
por: Kelly, Aaron S, et al.
Publicado: (2020)

SAT-LB018 Different Definitions of Sarcopenia and Its Correlations with Anthropometric Measurements, Body Composition, Handgrip Strength, Metabolic Profile and Bone Mineral Density in Obese Women
por: Carvalho, Nara, et al.
Publicado: (2019)

OR20-2 Oxytocin Significantly Attenuates the Functional Connectivity between Food Motivation Brain Areas in Overweight and Obese Men Exposed to High Caloric Food Images
por: Kerem, Liya, et al.
Publicado: (2019)

RF24 | PSUN110 A Cross-Sectional Study Evaluating the Impact of Combined Hormonal Contraceptives on Components of Energy Balance in Pre-Menopausal Women with Overweight or Obesity
por: Zaman, Adnin, et al.
Publicado: (2022)

MON-594 The Peculiarity of the Gut Microbiota in Patients with Different Phenotypes of Obesity (Pilot Study)
por: Volkova, Natalia, et al.
Publicado: (2020)

FRI067 Efficacy And Safety Of Glucagon-like Peptide 1 Analogs And Agonists (aGLP1) In Overweight/Obese Patients: A Systematic Review And An Updated Network Meta-analysis
por: Silva, Caroliny Hellen, et al.
Publicado: (2023)

Gut Microbiome and Intestinal Permeability Are Promising Targets for Treating Nonalcoholic Fatty Liver Disease
por: Heshmati, Hassan Massoud
Publicado: (2021)

MON-588 Anthropometric Parameters, Body Fat Percentage and Metabolic Profile in Sarcopenic Women with Recommendation for Bariatric Surgery
por: Carvalho, Nara Nóbrega Crispim, et al.
Publicado: (2020)

Higher Peptide YY Levels Are Associated With Lower Bone Mineral Density in Low Weight Adolescent Girls With Avoidant/Restrictive Food Intake Disorder
por: Sella, Aluma Chovel, et al.
Publicado: (2021)

Mice Deficient for an Intestinal G Protein-Coupled Receptor Expression Have Increased Satiety During Rebound Hyperphagia
por: Yan, Shijun, et al.
Publicado: (2021)

OR23-4 Intestinal FFA2 and FFA3 Mediate Obesogenic Effects in Mice on a Western Diet
por: Gough, Sophie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekma0tdf3kd1fp1i7uki7t26rv